People · Operator
Named in public records as an officer, director or promoter · active 2011–2024 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| GenturaDx, Inc. | — | Biotechnology | Series A | $4.0M | $144.8M | 2011 |
| Xella Health, PBC | — | Biotechnology | Pre-Seed | $600K | $2.9M | 2024 |
Jesus Ching at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Jesus Ching on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| MIN CUI | 1 | 5 |
| Mark Bagnall | 1 | 3 |
| Phillip Lee | 1 | 2 |
| Joseph Tian | 1 | 1 |
| Deborah Wright | 1 | 1 |
| Steven Yu | 1 | 1 |
| Adriana Dantas Lemberg | 1 | 1 |
| Kelly Lacob | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.